| ANETArista Networks, Inc. |
9 mld USD |
39,0% |
2025 |
| ARLOArlo Technologies, Inc. |
529,3 mln USD |
2,8% |
2025 |
| ARMPArmata Pharmaceuticals, Inc. |
b.d. |
b.d. |
2025 |
| ARRArmour Residential REIT, Inc. |
b.d. |
b.d. |
2025 |
| ARQArq, Inc. |
120,3 mln USD |
-43,7% |
2025 |
| ARQQArqit Quantum Inc. |
293 tys. USD |
-18 628,3% |
2024 |
| ARRYArray Technologies, Inc. |
1,3 mld USD |
-4,1% |
2025 |
| AVBPArriVent BioPharma, Inc. |
b.d. |
b.d. |
2025 |
| BANXArrowMark Financial Corp. |
b.d. |
b.d. |
b.d. |
| AIPArteris, Inc. |
70,6 mln USD |
-49,2% |
2025 |
| AJGArthur J. Gallagher & Co. |
13,9 mld USD |
10,7% |
2025 |
| APAMArtisan Partners Asset Management Inc. |
1,2 mld USD |
24,3% |
2025 |
| ARTVArtiva Biotherapeutics, Inc. |
0 USD |
b.d. |
2025 |
| ARXSArxis, Inc. |
b.d. |
b.d. |
b.d. |
| ASANAsana, Inc. |
790,8 mln USD |
-23,9% |
2026 |
| ASNDAscendis Pharma A/S |
720,1 mln € |
-31,7% |
2025 |
| SORAAsiaStrategy |
11 mln USD |
111,9% |
2025 |
| ALABAstera Labs, Inc. |
852,5 mln USD |
25,7% |
2025 |
| ASTHAstrana Health, Inc. |
3,2 mld USD |
0,7% |
2025 |
| ALOTAstroNova, Inc. |
150,5 mln USD |
-1,6% |
2026 |
| ATAIAtaiBeckley Inc. |
4,1 mln USD |
-16 142,0% |
2025 |
| ATRAAtara Biotherapeutics, Inc. |
120,8 mln USD |
27,1% |
2025 |
| AVIRAtea Pharmaceuticals, Inc. |
b.d. |
b.d. |
2025 |
| ASICAtegrity Specialty Insurance Co Holdings |
424,3 mln USD |
17,4% |
2025 |
| ATHSAthene Holding Ltd. |
25,7 mld USD |
10,6% |
2025 |
| ATKRAtkore Inc. |
2,9 mld USD |
-0,5% |
2025 |
| AUBAtlantic Union Bankshares Corp |
b.d. |
b.d. |
2025 |
| ATLCAtlanticus Holdings Corp |
2 mld USD |
6,2% |
2025 |
| AESIAtlas Energy Solutions Inc. |
1,1 mld USD |
-4,6% |
2025 |
| ATLXAtlas Lithium Corp |
121,4 tys. USD |
-23 157,6% |
2025 |
| TEAMAtlassian Corp |
6,6 mld USD |
-0,8% |
2026 |
| ATMUAtmus Filtration Technologies Inc. |
1,8 mld USD |
11,8% |
2025 |
| ATOMAtomera Inc |
65 tys. USD |
-31 036,9% |
2025 |
| ATATAtour Lifestyle Holdings Ltd |
1,4 mld USD |
16,6% |
2025 |
| ATRCAtriCure, Inc. |
534,5 mln USD |
-2,1% |
2025 |
| RNAAtrium Therapeutics, Inc. |
b.d. |
b.d. |
b.d. |
| ATTOAttovia Therapeutics, Inc. |
b.d. |
b.d. |
b.d. |
| AURAAura Biosciences, Inc. |
b.d. |
b.d. |
2025 |
| AUGOAura Minerals Inc. |
b.d. |
b.d. |
b.d. |
| AUREAurelion Inc. |
639,9 tys. USD |
-1074,7% |
2024 |
| PUSAAureus Greenway Holdings Inc |
3 mln USD |
-124,0% |
2025 |
| AUPHAurinia Pharmaceuticals Inc. |
283,1 mln USD |
101,5% |
2025 |
| AURAurora Innovation, Inc. |
3 mln USD |
-27 200,0% |
2025 |
| ADSKAutodesk, Inc. |
7,2 mld USD |
15,6% |
2026 |
| ATHMAutohome Inc. |
922,6 mln USD |
22,4% |
2025 |
| AUTLAutolus Therapeutics plc |
75,4 mln USD |
-381,4% |
2025 |
| AVTXAvalo Therapeutics, Inc. |
59 tys. USD |
-132 642,4% |
2025 |
| AVLNAvalyn Pharma Inc. |
b.d. |
b.d. |
b.d. |
| AVTRAvantor, Inc. |
6,6 mld USD |
-8,1% |
2025 |
| AVPTAvePoint, Inc. |
419,5 mln USD |
8,3% |
2025 |